CELP had some volume today.

You spoke too soon. Just traded.

i was thinkin about the same thing,,.. what if its not registered as BK and shares were never cancelled

ANYONE KNOW WHU NO TRADE UNTIL NOW?

.. what would happen if some lawyer messed up and this company is NOT actually private!!!! --- ie the bankruptcy proceedings never declared the shares as worthless?

This about summarizes everything I have read on this board. Looks as if noone ever filed to deregister CELP, and the stock has been trading ever since, although very quietly until yesterday.

Interesting situation ...

P.S. I am NOT a bagholder, just a quiet observer. Maybe something I can learn from this.

Sielent Board

Everything about the pr is true...except that zepto is a private company and cellular (celp) doesn't exist.

Zeptometrix is CELP per M2 presswire release

M2 "Press Wire "

M2 PressWIRE - March 21, 2007 - Rochester, NY -- OTCStockExchange.com's "Mid-Day Stock Watch Alert" this afternoon are 5G Wireless Communications, Inc. (OTCBB: FGWI), Banyan Corporation (OTCBB: BANY), Pegasus Wireless Corporation (OTCBB: PGSW), ZeptoMetrix Corp. (Pink Sheets: CELP).

ZeptoMetrix Corp. (Pink Sheets: CELP - http://finance.yahoo.com/q?s=CELP.PK )

ZeptoMetrix, formerly called Cellular Products, has previously supplied HIV and other infectious agents under CDC contracts. ZeptoMetrix Corp. will produce flu viruses -- including strains of avian influenza or "bird flu" -- under a multimillion-dollar U.S. contract, the Buffalo company is announcing today. The viruses are used by makers of diagnostics to develop tests for dangerous strains. The selection of ZeptoMetrix gives the 30-person company a role in the U.S. effort to prevent a deadly flu outbreak, company officials said. "What we're doing here could help save millions and millions of lives," marketing director Mark Rowland said.

The contract, for an undisclosed sum, comes from the U.S. Centers for Disease Control and Prevention and the Department of Health and Human Services. The company expects to grow at least 150 different strains of flu virus over four years, with expectations for follow-on work, a statement said. Company president James Hengst and Chairman Christopher Collins plan a press conference this morning. Bird flu has infected 200 people in Asia and Africa, more than half of whom died, according to the CDC. So far its transmission between humans has been limited, but that could change as mutant variants emerge. Test makers need examples of the virus to make diagnostics that distinguish between ordinary flu strains and fatal ones, Rowland said. As new strains emerge globally, ZeptoMetrix will receive samples to "grow up" in batches for test makers. Its two biohazard labs on Main Street have federal clearance for handling disease agents. It also has a proprietary process for deactivating viruses, making them safe to handle, Rowland said. At the 15,000-square-foot building near the city's medical campus, workers in biohazard suits work with viruses in labs that they enter through an airlock. The anti-pandemic plan is to diagnose dangerous strains rapidly in order to isolate infected regions and individuals.

"Once a pandemic begins, it cannot be stopped easily," the CDC's Influenza Pandemic Operation Plan says. "However, it can be slowed, giving the U.S. time to prepare... and distribute antivirals, vaccines and other countermeasures."

ZeptoMetrix has worked on other dangerous viruses for HIV testing and whooping cough. It has also launched a joint venture with a New Zealand company to develop therapies for bioterrorism weapons like anthrax and botulism. A sister facility in Franklin, Mass., stores blood samples with certain antibodies taken from more than a million people for drug research.

He didn't give a specific date but he implied that it was in recent memory. The way the SEC works and as busy as he is that could mean 6 months, a year maybe? Even a month...I didn't ask him specifically.

Knight Rider news just posted the same story from buffalo news on micro-cap news as a pr release at 5:03pm est and attributed it to CELP symbol.

Did he say when they sent him notice that Cellular Products is delinquent on their filings?

Good question.

The CEO, Dr. Hengst called me and told me that he assumed that the bankruptcy court filed the article 15 he thinks needed to be filed but they must not have. He told me that this was done back in 1994..and the Hemagen liquidated in 1996. He said that Cellular sold all their assets to Hemagen including their name, and it was dissolved. He did say however that the SEC sent him notice that Cellular Products is delinquent on their filings. He said he has some calls into the SEC but they haven't gotten back to him. I had called and left a message and since they had received a number of calls he clled me back cause he didn't want anyone throwing money away at a stock that didn't exist.Nice guy.

How does a stock that doesn't exist still trade...and where does the money go?

Hmmm.. what would happen if some lawyer messed up and this company is NOT actually private!!!! --- ie the bankruptcy proceedings never declared the shares as worthless? It would take a lawyer and time to figure it out but wouldn't that be a story huh?? hahhaha... ;) Wish I had the bravado to buy, hold, and find out but I'm just a little guy.

20,000 trade @ 0.15 just went through!

mine also now, there were no trades from 14:11 to 15:43

my L2 shows last trade at 3:45 est. 7,000 shares @ .012

is this POS still trading it may of been stoped at 2:11 the chart just stops..http://moneycentral.msn.com/investor/charts/chartdl.aspx?C6=2007&PeriodType=0&ShowChtBt=Refr...

Cellular Products (CELP) doesn't even exist! They have no assets. The company was dissolved and just has never been de-listed!!! Talk about selling air shares...this company shouldn't even be trading!

.Just got of the phone with ZeptoMetrix Corp. they have no idea why these shares are trading they thought the shares were dissolved during the bankrupcy.They are a private company http://www.buffalonews.com/258/story/37050.html

Another thing I noticed that gives me a bad feeling about this is that if you read the news release it is from a newspaper in Buffalo. It mentions ZeptoMetrix corp but does not make any mention of being publicly traded nor is CELP seen anywhere in the article.

I couldn't even find CELP on Reuters.

In the biotechnology field, Chris and James Hengst, President & CEO, purchased
Cellular Products Inc. and formed ZeptoMetrix in July 1999 followed by the April 2004 purchase of Impath BioClinical
Partners located in Franklin, MA. In addition to ZeptoMetrix, Chris and Jim formed Buckler Biodefense Corporation in 2006 in partnership with Virionyx, Ltd., located in Auckland, New Zealand http://www.zeptometrix.com/zeptogramwinter07.pdf

CPI continued to be financially troubled, was bought and sold a couple of times and even went through a chapter 11 bankruptcy. In the mid 90's Dr. Jim Hengst came to Buffalo, became head of CPI, and restructured the company to focus on its research products market. In 1999, Jim, together with Chris Collins, now our chairman, bought CPI from Hemagen Diagnostics and renamed the organization, ZeptoMetrix.http://www.zeptometrix.com/company.htm http://www.zeptometrix.com/bottom.htm

Wow, whats going on with this stock? Somebody made a killing, and some holding the bag? Is this company privately owned?


This is what was delivered to my mailbox, so went to check it out . Thought wow good news, then read post on this board and now thinking something doesnt add up or messed up.


CELP - NAME CHANGE WITH HUGE NEWS
http://finance.yahoo.com/q?s=CELP.PK
ZeptoMetrix Corp. will produce flu viruses -- including strains of avian influenza or "bird flu" -- under a multimillion-dollar U.S. contract, the Buffalo company is announcing today. The viruses are used by makers of diagnostics to develop tests for dangerous strains. The selection of ZeptoMetrix gives the 30-person company a role in the U.S. effort to prevent a deadly flu outbreak, company officials said. "What we're doing here could help save millions and millions of lives," marketing director Mark Rowland said. The contract, for an undisclosed sum, comes from the U.S. Centers for Disease Control and Prevention and the Department of Health and Human Services. ZeptoMetrix, formerly called Cellular Products, has previously supplied HIV and other infectious agents under CDC contracts. The company expects to grow at least 150 different strains of flu virus over four years, with expectations for follow-on work, a statement said. Company president James Hengst and Chairman Christopher Collins plan a press conference this morning. Bird flu has infected 200 people in Asia and Africa, more than half of whom died, according to the CDC. So far its transmission between humans has been limited, but that could change as mutant variants emerge. Test makers need examples of the virus to make diagnostics that distinguish between ordinary flu strains and fatal ones, Rowland said. As new strains emerge globally, ZeptoMetrix will receive samples to "grow up" in batches for test makers. Its two biohazard labs on Main Street have federal clearance for handling disease agents. It also has a proprietary process for deactivating viruses, making them safe to handle, Rowland said. At the 15,000-square-foot building near the city's medical campus, workers in biohazard suits work with viruses in labs that they enter through an airlock. The anti-pandemic plan is to diagnose dangerous strains rapidly in order to isolate infected regions and individuals. "Once a pandemic begins, it cannot be stopped easily," the CDC's Influenza Pandemic Operation Plan says. "However, it can be slowed, giving the U.S. time to prepare . . . and distribute antivirals, vaccines and other countermeasures."

ZeptoMetrix has worked on other dangerous viruses for HIV testing and whooping cough. It has also launched a joint venture with a New Zealand company to develop therapies for bioterrorism weapons like anthrax and botulism. A sister facility in Franklin, Mass., stores blood samples with certain antibodies taken from more than a million people for drug research.

Zeptometrix (private) is majority owner of CELP (public).

See the article from 7/23/99 posted earlier which states:

"Hemagen netted $800,000 from the stock sale of CPI (CELP) to ZeptoMetrix Corporation, a company created by two of CPI’s senior managers for the purpose of purchasing CPI".

IMHO

they are still trading it tho....unbelievable.

Here is the e-mail reply I just received, after I had called the company.

Dear Rick,
ZeptoMetrix is a private company. Therefore, there are no shares of any kind.
Regards,
Anna

Head22, You are exactly right. I called the company and they are privately owned. I got sucked in and lost 50% when I sold 30 minutes ago at .015. By tomorrow it will probably be worthless.

exactly....but Zepto is a private company. CELP is damn near non-existent. They have to be more surprised than anyone that their stock is moving. If they even know that is.

here is the story...

Cellular Products went BK in 1994

then bought by Hemagen Diagnostics in 1996

then sold to Zeptometrix in 1999

if this is the case give us some details, contact information etc

interesting that message #9 got deleted, had details of phone conversation which was exact same thing which company told a friend of mine, this thing sounding worse all the time

New Contract with SUDI ARABIA MOC,co

ok. Contact them yourself at the Buffalo headqtrs. I'm sure they will be ticked off that they are getting called again.

CONTACT INFO

Headquarters Massachusetts Facility
872 Main Street 25 Kenwood Circle, Suite 6
Buffalo, NY 14202 Franklin, MA 02038
Ph: 716-882-0920 Ph: 508-553-5800
Toll Free: 800-274-5487
Toll Free: 866-520-0588
Fax: 716-882-0959

http://www.zeptometrix.com/contact.htm

They have New business and Big Contract they may posted next week .

Lier u want to buy cheap

http://www.zeptometrix.com

http://www.pinksheets.com/quote/company_profile.jsp?symbol=CELP

Company Notes:
Note=11-94 Company filed petition under Chapter XI of the Federal Bankruptcy Code in the Western District of New York. 10-96 purusant to an order of the Bankruptcy Court, company changed its name to 872 Main Street Corp. after sale of all its assets and the use of the name, Cellular Products, Inc., to Hemagen Diagnostics, Inc.

http://www.hemagen.com/PressRelease/pr072699.htm

HEMAGEN COMPLETES THE SALE OF CELLULAR PRODUCTS, INC.

WALTHAM, MA , Hemagen Diagnostics, Inc. (NASDAQ: HMGN, HMGNW, BSE: HGN) is pleased to announce that on Friday, July 23, 1999 it completed the sale of its wholly owned subsidiary, Cellular Products, Inc. (CPI) located in Buffalo, New York, to ZeptoMetrix Corporation.

Hemagen netted $800,000 from the stock sale of CPI to ZeptoMetrix Corporation, a company created by two of CPI’s senior managers for the purpose of purchasing CPI. "The sale is part of our strategic business plan in furtherance of our goals to increase profitability and reduce expenses in order to increase shareholder value," stated Dr. Franzblau president of Hemagen. "The sale of CPI allows Hemagen to focus on its core markets; point-of-care, immunodiagnostics, and clinical chemistry," added Dr. Franzblau.

During the present fiscal year, Hemagen has undertaken several cost cutting projects that should begin to show dividends in the first quarter of the next fiscal year. Hemagen has begun manufacturing Analyst instruments in its Waltham facility. Additional Analyst production will be brought in-house over the next 6 months. "We are particularly excited about bringing the manufacturing of the Analyst instrument in house to our Waltham facility which will further decrease our present expenses," said Dr. Franzblau.

Hemagen purchased CPI out of bankruptcy approximately two and one half years ago for $581,000 net of cash. The Hemagen purchase included approximately $250,000 in account receivables. During this present fiscal year, CPI was expected to lose approximately $240,000.

Hemagen Diagnostics, Inc. develops, manufactures and markets more than 135 FDA-cleared proprietary medical diagnostic test kits, and an FDA-cleared Clinical Chemistry Analyzer, for use in the diagnosis of autoimmune and infectious diseases and to measure important constituents in human and animal blood. The Company focuses on markets which offer significant growth opportunities.

Except for any historical information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, including those described in the Company’s Securities and Exchange Commission reports and filings.

http://finance.yahoo.com/q?s=HMGN.OB

50cent how you come up 1 by monday or irt is a pump

anyone come up with any more information on this?

I hope so.

$1 next monday

http://www.buffalonews.com/258/story/37050.html

now its deflating like a hot air muffin

CELP rtq 0.03 up 1400%